Juvenile dermatomyositis: Clinical characteristics and the relatively high risk of interstitial lung disease

Modern Rheumatology

Volumn 17, Issue 5, 2007, Pages 413-417

  Morinishi, Yoichi ^a,b   Oh Ishi, Tsutomu ^a   Kabuki, Tomoyuki ^a   Joh, Kosuke ^a  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Interstitial lung disease; Juvenile dermatomyositis; Steroid

Indexed keywords

ACETYLSALICYLIC ACID; ANTIGEN; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IBUPROFEN; IMMUNOGLOBULIN; KL 6 ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; MUSCLE ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ARTHRITIS; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE COURSE; DRUG MEGADOSE; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; INTERSTITIAL LUNG DISEASE; JAPANESE; LOW DRUG DOSE; MALE; MUSCLE WEAKNESS; MYALGIA; ONSET AGE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PROGNOSIS; RASH; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ANTIBODIES, ANTINUCLEAR; CA-15-3 ANTIGEN; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HUMANS; JAPAN; LUNG DISEASES, INTERSTITIAL; MALE; RETROSPECTIVE STUDIES; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 35348850039     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-007-0610-y     Document Type: Article

References (22)

1. LM Pachman JR Hayford A Chung CA Daugherty MA Pallansch CW Fink 1998 Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children J Rheumatol 25 1198-234 9632086 1:STN:280:DyaK1c3ptlyntQ%3D%3D
2. AM Huber B Lang CM LeBlanc N Birdi RK Bolaria P Malleson 2000 Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis Arthritis Rheum 43 541-9 10728746 10.1002/ 1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T 1:STN:280:DC%2BD3c7ptFSqsg%3D%3D
3. A Bohan JB Peter 1975 Polymyositis and dermatomyositis N Engl J Med 292 344-7 1090839 1:STN:280:CSqC3MfovVI%3D
4. Tanimoto K, Kano S, Nakano K, Nishitani H, Sato T. Revised diagnostic criteria of dermatomyositis/polymyositis (in Japanese). Annual Report: The Ministry of Health and Welfare of Japan, Results of a study in 1992. 1993; p. 25-8
5. N Kohno S Kyoizumi Y Awaya H Fukuhara M Yamakido M Akiyama 1989 New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6 Chest 96 68-73 2661160 1:STN:280:BiaB1cbitVA%3D
6. I Kobayashi M Yamada Y Takahashi N Kawamura M Okano Y Sakiyama 2003 Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A Rheumatology 42 371-4 12595639 10.1093/rheumatology/keg040 1:STN:280:DC%2BD3s%2FosVCktA%3D%3D
7. QA Al-Salmi JN Walter GN Colasurdo MM Sockrider EO Smith H Takahashi 2005 Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease Chest 127 403-7 15654008 10.1378/ chest.127.1.403 1:CAS:528:DC%2BD2MXht1Gnu7s%3D
8. I Kobayashi S Ono N Kawamura M Okano K Miyazawa H Shibuya 2001 KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis J Pediatr 138 274-6 11174630 10.1067/mpd.2001.110324 1:STN:280:DC%2BD3M7psVWktQ%3D%3D
9. T Hiketa Y Matsumoto M Ohashi R Sasaki 1992 Juvenile dermatomyositis: A statistical study of 114 patients with dermatomyositis J Dermatol 19 470-6 1401507 1:STN:280:ByyD3MjjvFw%3D
10. R Kikuchi Y Arai K Kaneko A Hidano 1985 Survey of 68 cases of childhood dermatomyositis, especially on its prognosis J Pediatr Dermatol 4 507-11
11. S Kobayashi K Higuchi H Tamaki Y Wada N Wada M Kubo 1997 Characteristics of juvenile dermatomyositis in Japan Acta Paediatr Jpn 39 257-62 9141268 1:STN:280:ByiB1cngvVY%3D
12. N Tomono M Mori S Nakajima T Miyamae S Ito T Mitsuda 2004 HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis J Rheumatol 31 1847-50 15338511 1:CAS:528:DC%2BD2cXosVKls7g%3D
13. JP Callen 2000 Dermatomyositis Lancet 355 53-7 10615903 10.1016/ S0140-6736(99)05157-0 1:STN:280:DC%2BD3c%2FotFKnuw%3D%3D
14. AL Norins 1989 Juvenile dermatomyositis Med Clin North Am 73 1193-239 2671541 1:STN:280:BiaA28zms1U%3D
15. AV Ramanan BM Feldman 2002 Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes Rheum Dis Clin North Am 28 833-57 12506775 10.1016/S0889-857X(02)00024-8 1:STN:280:DC%2BD3s%2FgtFWgsg%3D%3D
16. RK Winkelmann 1982 Dermatomyositis in childhood Clin Rheum Dis 8 353-68 6754231 1:STN:280:BiyD2M7psFY%3D
17. AB Kimball RM Summers M Turner EM Dugan J Hicks FW Miller 2000 Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy Arthritis Rheum 43 1866-73 10943878 10.1002/ 1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6 1:STN:280:DC%2BD3cvisVamsg%3D%3D
18. B Tabarki G Ponsot AM Prieur M Tardieu 1998 Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids Eur J Paediatr Neurol 2 235-11 10.1016/S1090-3798(98)80021-4
19. S Ito T Imagawa T Miyamae S Katakura M Mori J Tomono 1998 Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis (in Japanese) Ryumachi 38 785-92 10047716 1:STN:280:DyaK1M7lslantA%3D%3D
20. A Schnabel M Reuter J Biederer C Richter WL Gross 2003 Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment Semin Arthritis Rheum 32 273-84 12701038 10.1053/ sarh.2002.50012
21. H Kameda H Nagasawa H Ogawa N Sekiguchi H Takei M Tokuhira 2005 Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis J Rheumatol 32 1719-26 16142867 1:CAS:528:DC%2BD2MXhtFSktb7M
22. K Higuchi N Wada K Fukunaga S Kobayashi N Okabe M Kubo 1997 Childhood dermatomyositis: An analysis of clinical and laboratory features and the clinical course in 22 cases (in Japanese) Jpn J Pediatr 50 465-70